The Patent Finder

Esker Therapeutics, Inc.

Also on record
Records under this name other than patents Esker Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Esker Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,053,219Substituted Pyridines as TYK2 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,731,956Substituted 1,2,4-Triazoles as Intermediates in the Syntheisis of TYK2 Inhibitors
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,006,306Substituted Pyridazines as TYK2 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,060,343Substituted 1,2,4-Triazoles as Intermediates in the Synthesis of TYK2 Inhibitors
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,351,572Substituted 1,2,4-Triazoles as TYK2 Inhibitors
Formerly held
In force
 · Low confidence
In forceLow confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited